Literature DB >> 12051675

Covalent reactivity of phosphonate monophenyl esters with serine proteinases: an overlooked feature of presumed transition state analogs.

Yasuhiro Nishiyama1, Hiroaki Taguchi, Jin-Quan Luo, Yong-Xin Zhou, Gary Burr, Sangeeta Karle, Sudhir Paul.   

Abstract

Phosphonate monoesters have been assumed to serve as noncovalent transition state analogs for enzymes capable of catalyzing transacylation reactions. Here, we present evidence for the covalent reaction of certain serine proteinases and peptidase antibody fragments with monophenyl amino(4-amidinophenyl)methanephosphonate derivatives. Stable adducts of the N-biotinylated monophenyl ester with trypsin and antibody fragments were evident under conditions that disrupt noncovalent interactions. The reaction was inhibited by the active-site-directed reagent diisopropyl fluorophosphate. Mass spectrometry of the fragments from monoester-labeled trypsin indicated phosphonylation of the active site. Irreversible inhibition of trypsin- and thrombin-catalyzed hydrolysis of model substrates was observed. Kinetic analysis of inactivation of trypsin by the N-benzyloxycarbonylated monoester suggested that the first-order rate constant for formation of covalent monoester adducts is comparable to that of the diester adducts (0.47 vs 2.0 min(-1)). These observations suggest that the covalent reactivity of phosphonate monoesters contributes to their interactions with serine proteinases, including certain proteolytic antibodies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12051675     DOI: 10.1016/S0003-9861(02)00087-5

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  7 in total

1.  Constitutive production of catalytic antibodies to a Staphylococcus aureus virulence factor and effect of infection.

Authors:  Eric L Brown; Yasuhiro Nishiyama; Jesse W Dunkle; Shreya Aggarwal; Stephanie Planque; Kenji Watanabe; Keri Csencsits-Smith; M Gabriela Bowden; Sheldon L Kaplan; Sudhir Paul
Journal:  J Biol Chem       Date:  2012-02-02       Impact factor: 5.157

2.  Antigen-specific proteolysis by hybrid antibodies containing promiscuous proteolytic light chains paired with an antigen-binding heavy chain.

Authors:  Gopal Sapparapu; Stephanie A Planque; Yasuhiro Nishiyama; Steven K Foung; Sudhir Paul
Journal:  J Biol Chem       Date:  2009-06-19       Impact factor: 5.157

3.  Constant domain-regulated antibody catalysis.

Authors:  Gopal Sapparapu; Stephanie Planque; Yukie Mitsuda; Gary McLean; Yasuhiro Nishiyama; Sudhir Paul
Journal:  J Biol Chem       Date:  2012-09-04       Impact factor: 5.157

4.  Naturally occurring catalytic antibodies: evidence for preferred development of the catalytic function in IgA class antibodies.

Authors:  Yukie Mitsuda; Stephanie Planque; Mariko Hara; Robert Kyle; Hiroaki Taguchi; Yasuhiro Nishiyama; Sudhir Paul
Journal:  Mol Biotechnol       Date:  2007-06       Impact factor: 2.695

5.  Exceptional amyloid beta peptide hydrolyzing activity of nonphysiological immunoglobulin variable domain scaffolds.

Authors:  Hiroaki Taguchi; Stephanie Planque; Gopal Sapparapu; Stephane Boivin; Mariko Hara; Yasuhiro Nishiyama; Sudhir Paul
Journal:  J Biol Chem       Date:  2008-10-30       Impact factor: 5.157

6.  Metal-dependent amyloid β-degrading catalytic antibody construct.

Authors:  Yasuhiro Nishiyama; Hiroaki Taguchi; Mariko Hara; Stephanie A Planque; Yukie Mitsuda; Sudhir Paul
Journal:  J Biotechnol       Date:  2014-04-01       Impact factor: 3.307

7.  Toward effective HIV vaccination: induction of binary epitope reactive antibodies with broad HIV neutralizing activity.

Authors:  Yasuhiro Nishiyama; Stephanie Planque; Yukie Mitsuda; Giovanni Nitti; Hiroaki Taguchi; Lei Jin; Jindrich Symersky; Stephane Boivin; Marcin Sienczyk; Maria Salas; Carl V Hanson; Sudhir Paul
Journal:  J Biol Chem       Date:  2009-09-02       Impact factor: 5.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.